¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Accu-Chek II/IIM/III Control InVt"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
factor III
Á¦3ÀÎÀÚ
accuracy control
Á¤È®µµ°ü¸®
awaking drug control law
°¢¼ºÁ¦Á¶Àý¹ý
air pollution control
´ë±â¿À¿°°ü¸®
biologics control laboratory
»ý¹°Á¦Á¦°ü¸®½ÃÇè¼Ò
birth control
»ê¾ÆÁ¦ÇÑ
bite control
±³ÇÕÁ¶Á¤
communicable disease control
Àü¿°º´°ü¸®
conception control
¼öÅÂÁ¶Àý
control
1. ÅëÁ¦, Á¦¾î 2. ´ëÁ¶ 3. °ü¸®
control analysis
ÁöµµºÐ¼®
control experiment
´ëÁ¶½ÇÇè
control gene
Á¦¾îÀ¯ÀüÀÚ
control group
´ëÁ¶±º
control mechanism
Á¶Àý±âÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
7
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
control
1. ÅëÁ¦, Á¦¾î, 2. ´ëÁ¶, 3. °ü¸®
quality control
Á¤µµ°ü¸®, ǰÁú°ü¸®, Áú°ü¸®
reflex control
¹Ý»çÁ¶Àý
safety control
¾ÈÀü°ü¸®
sugar control
Ç÷´çÁ¶Àý
impulse control disorder
Ãæµ¿Á¶ÀýÀå¾Ö, Ãæµ¿Á¶Àýº´
case-control study
ȯÀÚ´ëÁ¶±º¿¬±¸
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
accuracy control
Á¤È®µµ°ü¸®
air pollution control
´ë±â¿À¿°°ü¸®
awaking drug control law
°¢¼ºÁ¦Á¶Àý¹ý
control analysis
ÁöµµºÐ¼®
biologics control
»ý¹°Á¦Á¦°ËÁ¤
biologics control laboratory
»ý¹°Á¦Á¦°ü¸®½ÃÇè¼Ò
birth control
»ê¾ÆÁ¦ÇÑ
bite control
±³ÇÕÁ¶Á¤
control
ÅëÁ¦, Á¦¾î, ´ëÁ¶, °ü¸®
case-control study
(¢¡retrospective) ÈÄÇ⿬±¸, µÞ¹æÇ⿬±¸
communicable disease control
Àü¿°º´°ü¸®
conception control
¼öÅÂÁ¶Àý
control equipment
Á¦¾îÀåÄ¡
control experiment
´ëÁ¶½ÇÇè
control gene
Á¦¾îÀ¯ÀüÀÚ
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
DSM-III
Á¤½ÅÀå¾Ö(º´)Áø´ÜÅë°èÆí¶÷ Á¦ 3ÆÇ
DSM-III-R
Á¤½ÅÀå¾Ö(º´)Áø´ÜÅë°èÆí¶÷ Á¦ 3ÆÇ °³Á¤ÆÇ
Sudan III
¼ö´Ü III
antithrombin III
Çׯ®·Òºó III
apolipoprotein C-III
¾ÆÆ÷Áö´Ü¹é C-III
arsenazo III dye
¾Æ¸£¼¼³ªÁ¶<ºñ¼Ò¾ÆÁ¶> III ¿°·á
group III fiber
Á¦¥²¤Çí·A.
group III fiber
Á¦¥²±º¼¶À¯(ÏØàéë«).
hyperlipoproteinemia type III
°íÁö´Ü¹éÇ÷Áõ III
hyperproteinemia type III
´Ü¹é°úÀ×Ç÷(Áõ) III Çü
hypersensitivity reactions,type iii(imune complex-mediated)
IIIÇü
platelet factor III
Ç÷¼ÒÆÇÁ¦»ïÀÎÀÚ.
procollagen III peptide
ÇÁ·ÎÄݶó°Õ III ÆéƼµå
pseudounipolar(bipolar III) disorder
°¡¼º ´Ü±Ø¼º(¾ç±Ø¼º III)Àå¾Ö(º´).
AGC (automatic gain control)
ÀÚµ¿ °ÔÀÎ Á¶Àý
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antithrombin III
Çׯ®·Òºó III
apolipoprotein C-III
¾ÆÆ÷Áö´Ü¹é C-III
arsenazo III dye
¾Æ¸£¼¼³ªÁ¶<ºñ¼Ò¾ÆÁ¶> III ¿°·á
group III fiber
Á¦¥²±º¼¶À¯(ÏØàéë«).
group III fiber
Á¦¥²¤Çí·A.
hyperlipoproteinemia type III
°íÁö´Ü¹éÇ÷Áõ III
hyperproteinemia type III
´Ü¹é°úÀ×Ç÷(Áõ) III Çü
hypersensitivity reactions,type iii(imune complex-mediated)
IIIÇü
oculomotor nerve (iii)
´«µ¹¸²½Å°æ
os metacarpale III ³ª
¼Â°¼Õ¹Ù´Ú<Áß¼ö>»À, Á¦»ïÁß¼ö°ñ(ð¯ß²ñéâ¢Íé).
platelet factor III
Ç÷¼ÒÆÇÁ¦»ïÀÎÀÚ.
procollagen III peptide
ÇÁ·ÎÄݶó°Õ III ÆéƼµå
pseudounipolar(bipolar III) disorder
°¡¼º ´Ü±Ø¼º(¾ç±Ø¼º III)Àå¾Ö(º´).
third arch (iii)
¼Â°±ÁÀÌ
type III human T lymphotropic virus
IIIÇü ÀÎ t¸²ÇÁ¿µ¾ç¼º ¹ÙÀÌ·¯½º
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½